Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control
Veeva Systems (NYSE: VEEV) announced increasing momentum for Veeva Vault LIMS, a cloud solution that simplifies quality control (QC) processes. Vault LIMS is unified with Veeva Vault Quality, enabling customers to share data across quality applications for more informed batch release decisions. The solution aims to bring together quality assurance (QA) and QC to improve efficiency, compliance, and right-first-time execution.
Forge Biologics' senior director of QC analytical testing, Andrew Laughhunn, highlighted the potential for streamlined method execution and minimized documentation errors. Vault LIMS offers a complete QC management and test execution solution that can be deployed quickly, reducing reliance on IT teams and lowering total cost of ownership. The solution is suitable for both established organizations and fast-growing biotechs.
Veeva Systems (NYSE: VEEV) ha annunciato un aumento dell'inerzia per Veeva Vault LIMS, una soluzione cloud che semplifica i processi di controllo qualità (QC). Vault LIMS è integrato con Veeva Vault Quality, permettendo ai clienti di condividere i dati tra le applicazioni di qualità per prendere decisioni più informate sui rilasci dei lotti. La soluzione si propone di unire la garanzia della qualità (QA) e il QC per migliorare l'efficienza, la conformità e l'esecuzione al primo tentativo.
Il direttore senior del testing analitico QC di Forge Biologics, Andrew Laughhunn, ha sottolineato il potenziale per un'esecuzione dei metodi semplificata e una riduzione degli errori di documentazione. Vault LIMS offre una soluzione completa per la gestione del QC e l'esecuzione dei test che può essere implementata rapidamente, riducendo la dipendenza dai team IT e abbassando il costo totale di proprietà. La soluzione è adatta sia per organizzazioni consolidate che per biotecnologie in rapida crescita.
Veeva Systems (NYSE: VEEV) anunció un aumento del impulso para Veeva Vault LIMS, una solución en la nube que simplifica los procesos de control de calidad (QC). Vault LIMS está unificado con Veeva Vault Quality, lo que permite a los clientes compartir datos entre aplicaciones de calidad para tomar decisiones más informadas sobre el lanzamiento de lotes. La solución busca unir la garantía de calidad (QA) y el QC para mejorar la eficiencia, el cumplimiento y la ejecución correcta desde el primer intento.
Andrew Laughhunn, director senior de pruebas analíticas QC en Forge Biologics, destacó el potencial de una ejecución de métodos más ágil y la minimización de errores de documentación. Vault LIMS ofrece una solución completa para la gestión de QC y la ejecución de pruebas que puede implementarse rápidamente, reduciendo la dependencia de los equipos de TI y disminuyendo el costo total de propiedad. La solución es adecuada tanto para organizaciones consolidadas como para biotecnologías de rápido crecimiento.
Veeva Systems(NYSE: VEEV)는 품질 관리(QC) 프로세스를 간소화하는 클라우드 솔루션인 Veeva Vault LIMS에 대한 상승세를 발표했습니다. Vault LIMS는 Veeva Vault Quality와 통합되어 고객이 품질 애플리케이션 간에 데이터를 공유하여 더 많은 정보에 기반한 배치 릴리스 결정을 내릴 수 있도록 합니다. 이 솔루션은 품질 보증(QA)와 QC를 통합하여 효율성, 규정 준수 및 올바른 첫 시도 실행을 개선하는 것을 목표로 합니다.
Forge Biologics의 QC 분석 테스트 수석 이사인 Andrew Laughhunn은 간소화된 방법 실행과 문서 오류 최소화의 잠재력을 강조했습니다. Vault LIMS는 신속하게 배포할 수 있는 완전한 QC 관리 및 테스트 실행 솔루션을 제공하여 IT 팀에 대한 의존도를 줄이고 총 소유 비용을 낮출 수 있습니다. 이 솔루션은 확립된 조직과 빠르게 성장하는 생명공학 기업 모두에 적합합니다.
Veeva Systems (NYSE: VEEV) a annoncé une dynamique croissante pour Veeva Vault LIMS, une solution cloud qui simplifie les processus de contrôle de qualité (CQ). Vault LIMS est intégré à Veeva Vault Quality, permettant aux clients de partager des données entre les applications de qualité afin de prendre des décisions de libération de lots plus éclairées. La solution vise à réunir l'assurance qualité (AQ) et le CQ pour améliorer l'efficacité, la conformité et l'exécution dès le premier essai.
Andrew Laughhunn, directeur senior des tests analytiques CQ chez Forge Biologics, a souligné le potentiel d'une exécution de méthodes rationalisée et d'une réduction des erreurs de documentation. Vault LIMS offre une solution complète de gestion du CQ et d'exécution des tests qui peut être déployée rapidement, réduisant ainsi la dépendance aux équipes informatiques et abaissant le coût total de possession. La solution convient aussi bien aux organisations établies qu'aux biotechnologies en forte croissance.
Veeva Systems (NYSE: VEEV) hat eine steigende Dynamik für Veeva Vault LIMS angekündigt, eine Cloud-Lösung, die die Prozesse der Qualitätskontrolle (QC) vereinfacht. Vault LIMS ist mit Veeva Vault Quality vereint, was es den Kunden ermöglicht, Daten über Qualitätsanwendungen hinweg zu teilen, um informiertere Entscheidungen zur Chargenfreigabe zu treffen. Die Lösung zielt darauf ab, Qualitätssicherung (QA) und QC zusammenzuführen, um Effizienz, Compliance und die Ausführung beim ersten Versuch zu verbessern.
Andrew Laughhunn, Senior Director für QC-analytische Tests bei Forge Biologics, hob das Potenzial für eine optimierte Methodenimplementierung und die Minimierung von Dokumentationsfehlern hervor. Vault LIMS bietet eine umfassende Lösung für das QC-Management und die Testausführung, die schnell bereitgestellt werden kann, wodurch die Abhängigkeit von IT-Teams verringert und die Gesamtkosten des Eigentums gesenkt werden. Die Lösung eignet sich sowohl für etablierte Organisationen als auch für schnell wachsende Biotechnologieunternehmen.
- Increasing momentum for Veeva Vault LIMS product
- Unified solution with Veeva Vault Quality for improved data sharing
- Potential for streamlined operations and reduced documentation errors
- Quick deployment and lower total cost of ownership
- Suitable for both established and growing biotech companies
- None.
Veeva's Vault LIMS is gaining traction in the life sciences industry, offering a cloud-based solution that integrates quality control (QC) with quality assurance (QA). This unified approach streamlines processes, potentially reducing errors and improving efficiency in pharmaceutical manufacturing.
The system's ability to consolidate multiple QC management tools into a single platform could significantly reduce operational complexity and IT overhead. This is particularly beneficial for smaller biotech firms and virtual organizations that may lack extensive IT resources. The cloud-based nature of Vault LIMS also suggests easier scalability and lower upfront costs compared to traditional on-premise solutions.
However, the true test will be in the system's ability to handle complex regulatory requirements and integrate seamlessly with existing workflows. The adoption rate and user feedback in the coming months will be important indicators of Vault LIMS's long-term success in the market.
Veeva's expansion into the LIMS market represents a strategic move to capture a larger share of the life sciences software ecosystem. This could potentially increase Veeva's revenue per customer and strengthen its market position. The LIMS market is projected to grow at a CAGR of
Veeva's approach of unifying QA and QC processes aligns with the industry trend towards digital transformation and operational efficiency. If successful, this could lead to higher customer retention rates and potentially attract new clients from competitors. However, investors should monitor the adoption rate and any impact on Veeva's profit margins, as expanding into new product lines often involves significant R&D and marketing expenses.
While the news is positive, its immediate impact on Veeva's financials may be , given the typically long sales cycles in enterprise software.
Life sciences organizations now manage all quality control data and processes in one solution for greater efficiency and speed
"Adopting Veeva Vault LIMS to replace a paper-based documentation practice will streamline method execution and minimize documentation errors so we can deliver more value to clients," said Andrew Laughhunn, senior director of QC analytical testing at Forge Biologics. "The time and effort we can refocus on other priorities is exciting, along with the cost savings we will accrue. Using a modern LIMS, we can focus on testing, the results, and the science."
With Vault LIMS, customers are bringing together quality assurance (QA) and QC to improve efficiency, compliance, and right first time execution. By establishing a seamless quality workflow, companies optimize QC to drive test reliability and accuracy while reducing cycle times.
"Veeva Vault LIMS can significantly streamline lab operations by consolidating the numerous systems, paper processes, and spreadsheets currently used to manage QC into one application," said Jason Boyd, senior director, Veeva Vault LIMS. "We've worked closely with our early adopters to deliver a seamless user experience that simplifies QC processes, bringing greater productivity and speed to the manufacturing lab and virtual organizations leveraging partners."
For established organizations and fast-growing biotechs, Vault LIMS delivers a complete QC management and test execution solution that can be deployed quickly. This reduces the reliance on IT teams and lowers the total cost of ownership, making the adoption of an advanced LIMS easier for the business.
"Market dynamics and pricing pressures are compelling life sciences organizations to enhance operational efficiencies. Manufacturing QC organizations can play a crucial role in driving improvements by optimizing batch release testing," said Daniel R. Matlis, president of Axendia, Inc., a leading life sciences analyst and strategic advisory firm. "Veeva's LIMS application offers a dynamic, cloud-first solution that can be utilized by established biopharma organizations aiming to build capacity, as well as emerging companies looking to scale."
Learn how Vault LIMS is redefining QC management by attending a complete track of QC-focused sessions at Veeva R&D and Quality Summit. Life sciences industry professionals can register for the Sept. 9-10 event in
Additional Information
For more on Veeva Vault LIMS, visit: veeva.com/VaultLIMS
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 35 and 36), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-vault-lims-gains-momentum-as-companies-unify-quality-assurance-and-quality-control-302228151.html
SOURCE Veeva Systems
FAQ
What is Veeva Vault LIMS and how does it benefit life sciences companies?
How does Veeva Vault LIMS (VEEV) impact laboratory operations?
What advantages does Veeva Vault LIMS (VEEV) offer for batch release testing?
When and where can industry professionals learn more about Veeva Vault LIMS (VEEV)?
